Qsymia vs. Phentermine

See how Qsymia and Phentermine compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Qsymia combines phentermine with topiramate for FDA-approved long-term weight management, while phentermine alone is only approved for a few weeks of use.

  • Both drugs are Schedule IV controlled substances that suppress appetite, but Qsymia requires REMS pharmacy enrollment due to a birth defect risk.

  • Phentermine costs much less out of pocket than Qsymia, but Qsymia's dual mechanism is designed for more sustained weight loss over time.

Qsymia vs. Phentermine Drug Summary

Qsymia

Qsymia is a combination of phentermine, a stimulant appetite suppressant, and topiramate, an anticonvulsant that helps curb appetite and cravings. It is FDA-approved for chronic weight management in adults and in adolescents 12 and older with obesity or excess weight plus a related health condition. Qsymia is taken as one extended-release capsule daily, with the dose increased gradually over 12 to 16 weeks.

Phentermine

Phentermine is a stimulant appetite suppressant used on its own to jump-start weight loss. It is FDA-approved only for a few weeks of use in adults with obesity or excess weight plus a related risk factor, alongside diet and exercise. Phentermine is taken once daily as a tablet or capsule, usually at a fixed dose with no titration schedule.

Qsymia vs. Phentermine Side Effects

Qsymia

Most common
dry mouth (up to 19%)
insomnia (up to 11%)
paresthesia (up to 21%)
constipation (up to 16%)

Phentermine

Most common
dry mouth (reported)
insomnia (reported)
palpitation (reported)
tachycardia (reported)

Qsymia vs. Phentermine Dosage

Qsymia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 3.75 mg/23 mg once daily Days 1-14
Maximum dose 15 mg/92 mg once daily Week 17 onward
Dose changes 3 increases As tolerated

Phentermine

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 37.5 mg once daily At the start
Maximum dose 15 mg once daily If needed
Dose changes 1 increase As tolerated

Qsymia vs. Phentermine Indications

Qsymia

Qsymia is approved for chronic, ongoing weight management rather than a short course of treatment. It can be prescribed to adults with obesity, adults who are overweight with a related condition such as high blood pressure or type 2 diabetes, and adolescents 12 and older with obesity.

  • Adults with obesity (BMI 30 or higher)

  • Adults overweight with a weight-related condition

  • Adolescents 12 and older with obesity

  • Long-term, ongoing use

Phentermine

Phentermine is approved only as a short-term aid for weight loss, meant for a few weeks alongside diet, exercise, and behavior changes. It is prescribed for adults with obesity or for adults who are overweight with an added risk factor such as high blood pressure.

  • Adults with obesity (BMI 30 or higher)

  • Adults overweight with a risk factor (BMI 27+)

  • Short-term use only (a few weeks)

  • Adjunct to diet and exercise

Qsymia vs. Phentermine Pros and Cons

Qsymia

Qsymia's dual mechanism, combining an appetite suppressant with an anticonvulsant, is designed for sustained weight loss over months to years under ongoing medical supervision. Because of its risk of birth defects, it is only available through certified REMS-enrolled pharmacies, which adds an extra step for patients. This more involved regimen reflects its intended use for chronic, long-term treatment rather than a short course.

Pros

  • FDA-approved for long-term, chronic weight management

  • Approved for adolescents 12 and older

  • Dual mechanism may produce greater weight loss than phentermine alone

  • Simple once-daily dosing after titration

Cons

  • Requires REMS enrollment and certified pharmacy dispensing

  • Not safe in pregnancy; requires monthly pregnancy testing

  • More monitoring needed for mood, cognition, and heart rate

  • Costs roughly $200 to $350 per month without insurance, more than phentermine

Phentermine

Phentermine's single stimulant mechanism is meant for a short, defined course of treatment rather than ongoing use. It has decades of clinical history and a well-established safety profile, without the added anticonvulsant risks that come with Qsymia. Because it is not approved for long-term therapy, patients typically stop or switch to another option once the initial period ends.

Pros

  • Long history of clinical use since 1959

  • No REMS program or specialty pharmacy required

  • Simpler dosing without a multi-week titration schedule

  • Costs roughly $15 to $75 per month without insurance, far less than Qsymia

Cons

  • Approved for only a few weeks of use, not long-term treatment

  • Lacks the added appetite-suppressing mechanism of topiramate

  • Cardiovascular stimulant effects like rapid heartbeat may be more noticeable

  • May require switching to another therapy once the short course ends

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.